Application 202686
- Type
- ANDA
- Sponsor
- MYLAN LABS LTD
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ESOMEPRAZOLE SODIUM | ESOMEPRAZOLE SODIUM | INJECTABLE;INTRAVENOUS | EQ 20MG BASE/VIAL | No | No |
| 002 | ESOMEPRAZOLE SODIUM | ESOMEPRAZOLE SODIUM | INJECTABLE;INTRAVENOUS | EQ 40MG BASE/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A202686-001 | ESOMEPRAZOLE SODIUM | ESOMEPRAZOLE SODIUM | EQ 20MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | ||
| A202686-002 | ESOMEPRAZOLE SODIUM | ESOMEPRAZOLE SODIUM | EQ 40MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A202686-001 | ESOMEPRAZOLE SODIUM | EQ 20MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A202686-002 | ESOMEPRAZOLE SODIUM | EQ 40MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 011fe1cb6892… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202686-001 | ESOMEPRAZOLE SODIUM | EQ 20MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202686-002 | ESOMEPRAZOLE SODIUM | EQ 40MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 31067a03dcf5… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A202686-001 | ESOMEPRAZOLE SODIUM | EQ 20MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A202686-002 | ESOMEPRAZOLE SODIUM | EQ 40MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 6a471c1ec25d… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202686-001 | ESOMEPRAZOLE SODIUM | EQ 20MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202686-002 | ESOMEPRAZOLE SODIUM | EQ 40MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | fd3edfee7708… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202686-001 | ESOMEPRAZOLE SODIUM | EQ 20MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202686-002 | ESOMEPRAZOLE SODIUM | EQ 40MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | b8a1b40f171c… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202686-001 | ESOMEPRAZOLE SODIUM | EQ 20MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202686-002 | ESOMEPRAZOLE SODIUM | EQ 40MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 03ed91905a0d… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202686-001 | ESOMEPRAZOLE SODIUM | EQ 20MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202686-002 | ESOMEPRAZOLE SODIUM | EQ 40MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 2680178bc6a6… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202686-001 | ESOMEPRAZOLE SODIUM | EQ 20MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202686-002 | ESOMEPRAZOLE SODIUM | EQ 40MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 5bbf6a4d5a75… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202686-001 | ESOMEPRAZOLE SODIUM | EQ 20MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202686-002 | ESOMEPRAZOLE SODIUM | EQ 40MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | d8e5a09893c0… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A202686-001 | ESOMEPRAZOLE SODIUM | EQ 20MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A202686-002 | ESOMEPRAZOLE SODIUM | EQ 40MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | d06236e962d9… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202686-001 | ESOMEPRAZOLE SODIUM | EQ 20MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202686-002 | ESOMEPRAZOLE SODIUM | EQ 40MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 79d66fd596c7… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202686-001 | ESOMEPRAZOLE SODIUM | EQ 20MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202686-002 | ESOMEPRAZOLE SODIUM | EQ 40MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 301d65b070ca… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202686-001 | ESOMEPRAZOLE SODIUM | EQ 20MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202686-002 | ESOMEPRAZOLE SODIUM | EQ 40MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 1e350fbaab3a… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A202686-001 | ESOMEPRAZOLE SODIUM | EQ 20MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A202686-002 | ESOMEPRAZOLE SODIUM | EQ 40MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 8072bd15b7f6… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A202686-001 | ESOMEPRAZOLE SODIUM | EQ 20MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A202686-002 | ESOMEPRAZOLE SODIUM | EQ 40MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 5c6f7cd8ea54… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A202686-001 | ESOMEPRAZOLE SODIUM | EQ 20MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A202686-002 | ESOMEPRAZOLE SODIUM | EQ 40MG BASE/VIAL | INJECTABLE / INTRAVENOUS | AP | 2017-05-17 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A202686-001 | ESOMEPRAZOLE SODIUM | EQ 20MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A202686-002 | ESOMEPRAZOLE SODIUM | EQ 40MG BASE/VIAL | INJECTABLE / INTRAVENOUS | AP | 2017-05-17 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A202686-001 | ESOMEPRAZOLE SODIUM | EQ 20MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A202686-002 | ESOMEPRAZOLE SODIUM | EQ 40MG BASE/VIAL | INJECTABLE / INTRAVENOUS | AP | 2017-05-17 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A202686-001 | ESOMEPRAZOLE SODIUM | EQ 20MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A202686-002 | ESOMEPRAZOLE SODIUM | EQ 40MG BASE/VIAL | INJECTABLE / INTRAVENOUS | AP | 2017-05-17 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A202686-001 | ESOMEPRAZOLE SODIUM | EQ 20MG BASE/VIAL | INJECTABLE / INTRAVENOUS | 2017-05-17 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A202686-002 | ESOMEPRAZOLE SODIUM | EQ 40MG BASE/VIAL | INJECTABLE / INTRAVENOUS | AP | 2017-05-17 | 782e0a99824c… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2022-04-08 23:34 UTC | 2022-04 | A202686-002 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A202686-002 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A202686-002 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A202686-002 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A202686-002 | AP | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A202686-002 | AP | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A202686-002 | AP | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A202686-002 | AP | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A202686-002 | AP | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A202686-002 | AP | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A202686-002 | AP | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A202686-002 | AP | 1 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Esomeprazole sodium | ESOMEPRAZOLE SODIUM | Slate Run Pharmaceuticals, LLC | 23395673-116d-4a8e-b0ce-59f9ca5b3daf | 2026-06-22 | Warnings, Adverse reactions | Esomeprazole sodium ESOMEPRAZOLE SODIUM |
| Esomeprazole Sodium | ESOMEPRAZOLE SODIUM | Eugia US LLC | 45a15ba2-2aae-4edc-beaa-4a2357d87f32 | 2025-11-07 | Warnings, Adverse reactions | Esomeprazole Sodium ESOMEPRAZOLE SODIUM |
| Esomeprazole Sodium | ESOMEPRAZOLE SODIUM | Gland Pharma Limited | 9354958c-e997-41c8-8605-23f0a58993c0 | 2023-07-21 | Warnings, Adverse reactions | Esomeprazole Sodium ESOMEPRAZOLE SODIUM |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 67457-392 | Esomeprazole sodium | Esomeprazole sodium | Mylan Institutional LLC | ANDA | Current |
| 67457-392 | Esomeprazole sodium | Esomeprazole sodium | Mylan Institutional LLC | ANDA | Current |
| 67457-392 | Esomeprazole sodium | Esomeprazole sodium | Mylan Institutional LLC | ANDA | Current |
| 67457-392 | Esomeprazole sodium | Esomeprazole sodium | Mylan Institutional LLC | ANDA | Current |
| 67457-392 | Esomeprazole sodium | Esomeprazole sodium | Mylan Institutional LLC | ANDA | Current |
| 67457-392 | Esomeprazole sodium | Esomeprazole sodium | Mylan Institutional LLC | ANDA | Current |